Grants
Innosuisse, Venture Kick, EIC

Non-dilutive funding from public or philanthropic bodies. Very competitive, but with no return in equity.

Ticket
CHF 10K – 2.5M
Timeline
1 to 6 months
Complexity
3/5
Advantages
  • Zero dilution
  • Added credibility
  • Coaching often included
  • No repayment
Limits
  • Very competitive
  • Strict eligibility criteria
  • Mandatory reporting
  • Slow process (1–6 months)
Best suited for
University researchDeep tech / cleantechSocial impactPreclinical biotech
Equity
Shares / Partnership interests

Issuing new shares in exchange for capital. The standard route for start-ups with high growth potential.

Ticket
CHF 500K – 70M+
Timeline
2 to 4 months
Complexity
4/5
Advantages
  • No repayment
  • Smart money & network
  • Market validation
  • Long-term alignment
Limits
  • Founder dilution
  • Long process (2–4 months)
  • Partial loss of control
  • High legal costs
Best suited for
Deep techBiotechScaling SaaSHardware
Not sure? Take the 5-question diagnosis →